Immunome Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Immunome Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2019 to 2023.
  • Immunome Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$47.1M, a 984% decline year-over-year.
  • Immunome Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$305M, a 1291% decline year-over-year.
  • Immunome Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$107M, a 189% decline from 2022.
  • Immunome Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$36.9M, a 49.3% decline from 2021.
  • Immunome Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$24.7M, a 38.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$107M -$69.9M -189% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$36.9M -$12.2M -49.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$24.7M -$6.87M -38.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 -$17.8M -$7.39M -70.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 -$10.4M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.